Today's society practices liberal use of antibiotics, in both human life and farming (livestock). This, along with various environmental circumstances, may become factors that cause change in intestinal flora. As the intestinal microbiome accounts for 70~80% of human immunity, this may lead to higher risk of immune-related diseases such as atopy, asthma, Type 1DM, Crohn’s disease, and cancer.Cuome Bio strives to find a solution that focuses on the intestinal microbiome and immune system.Through continuous research, we have found significant health benefits in highly-concentrated probiotics, defined as over 1 trillion cells per intake. For patients with significantly weakened immunity, this may serve as a natural biological response modifier (BRM) to boost the immune system minus the side effects of pharmaceutical substances.By restoring the balance of numerous microbes that make up our body, we can prepare a fundamental basis for stronger immunity against diseases. This is a process that does not need to take place in a hospital, but as a daily routine in your home.
For too long we’ve put health and the environment in different boxes. We’re here to bridge the gap by connecting the health of people and the planet while planet health goes beyond climate change. Human health is rooted in the reliance of environmental & ecosystems currently under threat.The overuse of antibiotics and pesticide; chemically managed livestock and agricultural products; soil & water pollution are all pressing issues that our society needs to address. Cuomebio is solving various environmental problems by utilizing eco-friendly materials & microbes.
Establishment of more than 100 microbial product lines by applying various strains of high-concentrated pure probiotic cells (immuno-biotic) according to the specificity research data for each species & strain B2C foundation and CUOME platform establishment.
OEM, Raw material sales, B2B solution for production and delivery of Company-exclusive strains
High-efficiency immunomodulatory food development by utilizing extraction technology of cell components such as EVs(extracellular vesicles) or active ingredients.Raw material registration for natural medication & new drug development.Development of immuno-cancer drugs and autoimmune diseases medicine
Cell count measurement for both live and heat-treated probiotics and strain identification technology.Development of microarray kit, diagnostic kits for pathogenic bacterium & antibiotics resistant bacteria and animal/aquaculture organism diagnostic kit.
Study of natural·microorganisms and microbial-derived substances, animal/aquaculture drugs, substances for water quality improvement, CRO, agricultural biotechnology